Idera Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 97   

Articles published

IDRA 2.95 +0.06 (2.25%)
price chart
Biotech Stocks that your portfolio will love: Idera Pharmaceuticals Inc ...
They say good things come in threes. If so, biotech companies could be in for not just another year of outperformance, but another decade.
Healthcare Sector Movers: Idera Pharmaceuticals, Inc. (IDRA), Juno ...  WallStreet Scope
Zacks Short Term Rating on Idera Pharmaceuticals, Inc. (NASDAQ:IDRA)
Research firm Zacks has rated Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) and has ranked it at 3, indicating that for the short term the shares are a hold.
Healthcare Sector Movers: BioMarin Pharmaceutical Inc. (BMRN), Juno ...  WallStreet Scope
Biotech Stocks Buzz: RXi Pharmaceuticals Corp (RXII), Idera Pharmaceuticals ...
On the trading floor, shares of Idera Pharmaceuticals Inc (NASDAQ:IDRA) gained 5.91% to close at $2.69. The $302.30M company on June 29, 2015 announced that it has appointed Mark J. Casey as Senior Vice President, General Counsel and Secretary of ...
Analytic Report on Idera Pharmaceuticals Inc (NASDAQ:IDRA)
Idera Pharmaceuticals Inc (NASDAQ:IDRA) stock is currently trading 37.04% below its 52-week-high, 77.84% above its 52-week-low.
Idera Pharmaceuticals Shares Up (IDRA) on Steady Volume  IRA Market Report
Biotech Stocks that your portfolio will love - Idera Pharmaceuticals Inc ...  Wall Street Observer
Biotech Stocks to bet on: Idera Pharmaceuticals Inc (NASDAQ:IDRA), Sarepta ...
They say good things come in threes. If so, biotech companies could be in for not just another year of outperformance, but another decade.
Shares of Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) Drops by -4.15%
Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) has lost 4.15% during the past week and dropped 32.45% in the last 4 weeks.
Biotech Stocks Worth Chasing - Idera Pharmaceuticals Inc (NASDAQ:IDRA), CTI ...  Wall Street Observer
Biotech Stocks that your portfolio will love: Keryx Biopharmaceuticals (KERX ...  Wall Street Point
Idera Pharmaceuticals, Inc. Price Target Update
Idera Pharmaceuticals, Inc. (NASDAQ:IDRA): The mean estimate for the short term price target for Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) stands at $6.5 according to 2 Analysts. The higher price target estimate for the stock has been calculated at $7 ...
3 Sizzling Hot Biotech Stocks - Idera Pharmaceuticals Inc (NASDAQ:IDRA ...  Wall Street Observer
News Recap - Idera Pharmaceuticals Inc (IDRA), Rubicon Minerals Corp (RBY ...  Investor Wired
Active Movers of Yesterday: Idera Pharmaceuticals Inc (NASDAQ:IDRA), Kite ...
Idera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for oncology and rare diseases in the United States.
3 Biotech Stocks Getting Some Love - Immunomedics, Inc. (NASDAQ:IMMU), Idera ...
Immunomedics, Inc. (NASDAQ:IMMU) advanced 6.21% to end last trading session at $1.88. The company, on August XX, 2015, reported financial results for the fourth quarter and fiscal year ended June 30, 2015.
Short Interest Update of Idera Pharmaceuticals, Inc. (NASDAQ:IDRA)
Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) has witnessed a rise of 16.9% or 3,848,210 shares in its short figure. The short interest augmentation took it from 22,724,995 on June 15,2015 to 26,573,205 on June 30,2015.